500 mg, and acetazolamide 250 mg were initiated following which the patient reported improvement in his headache and went to sleep. The next morning he complained of a mild to moderate frontal and central headache, discomfort, and lassitude. There was no change in his vitals from the previous night. He was offered supervised portable altitude chamber (PAC) nursing for one hour along with acetaminophen and acetazolamide. There was transient improvement with rebound headache, tachycardia, tachypnea, and hypertension after a few hours. Severe AMS was suspected and PAC nursing was offered the second time for 2 hours with a 10-minute break in between. By this time, it was afternoon and the weather had deteriorated into complete whiteout followed by heavy snowfall leading to the complete disruption of communication. While the patient was being attended by the paramedic with assistance from fellow climbers, neither could he be monitored by the medical doctor, nor did the possibility for descent or evacuation exist. After the weather cleared and communication was re-established through a hand-held radio device, altered consciousness and altered vitals were reported by the paramedic. HACE was suspected. Immediate descent was planned from 6700 m/22000 ft to 5790 m/19000 ft. The descent was exacting as it had to be executed in the dark with limited human assistance over the crevasse-laden ice wall on a 70-degree incline. The patient was considered a lying casualty and was carried in a basket stretcher to the edge of the ice wall from where the stretcher was descended through top belay using static ropes with human assistance on one side to stabilize the stretcher along the decided route on the wall. The two crevasses on the ice-covered mountain slope were having the upper edge higher than the lower making it difficult to manoeuver the patient across it. The basket stretcher was slid carefully over the ladder with belay support from both sides. The descent to the base of the ice wall at 5950 m/19400 ft took three hours. The casualty was carried on snow scooter in a sitting position for 500 m to 5790 m/19000 ft where the doctor received the patient. He had altered consciousness, feeble pulse and respiration with oxygen saturation 65%. Blood pressure could not be recorded. He was offered passive rewarming: warm crystalloids and dexamethasone 8 mg. Oxygen and inotropes were not available. His condition deteriorated further leading to his demise despite aggressive resuscitative efforts. The casualty had no history of thrombophilic disorders, embolic phenomena, blood dyscrasias, collagen vascular diseases, stroke, encephalitis, intracranial abscess, meningitis, subdural empyema, systemic lupus erythematosus, hyperhomocysteinemia, nephrotic syndrome, hepatic cirrhosis, sarcoidosis, chronic inflammatory diseases, otorhinolaryngeal problems, malignancy, exposure to steroids, erythropoietin or heparin, head and neck trauma, or surgery. His body was dispatched by rotor-wing aircraft the next day. Post-mortem investigations revealed superior sagittal sinus thrombosis delineating the development of CVST at extreme altitude.
Discussion
Headache and discomfort after ascending can be due to altitude illness (AMS, HACE, acute hypoxic cerebral dysfunction/AHCD), CVST, migraine, fatigue, dehydration or hypoglycemia. Fatigue, dehydration, and hypoglycemia can coexist with AMS, HACE, AHCD, and CVST. Altitude illness being the most common should come first in differential diagnoses. AMS and HACE were diagnosed by Lake Louis consensus criteria as there was a recent gain in altitude. 6, 7 AHCD at extreme altitude may be pathophysiologically different from HACE. Migraine at altitude generally presents as headache with focal neurological symptoms. CVST is not only rare, but it is also a diagnostic and therapeutic challenge in extreme altitude. While it may present as a thunderclap headache, abnormal vision, symptoms of stroke, seizures, and focal neurological deficits, the presentation may be altered or oligosymptomatic at extreme altitude. Both HACE and CVST may present with headache as the only symptom, not relieved by acetaminophen as in this case. 6, 9 Altered vitals may point towards an uncompensated physiological state due either to the ascent, the altitude, or the movement of the patient on the mountains. CVST at extreme altitude can be spontaneous. 10 Prolonged hypobaric hypoxia and anoxia at extreme altitude can precipitate thrombosis through capillary damage, haematological alteration leading to increased viscosity due to secondary polycythemia, and a hypercoagulable state, especially because of the increased factor VIIa activity and platelet activation. 11, 12 CVST is sometimes associated with stroke, the possibility of which appears remote in this case, although it cannot be excluded. 13 CVST at altitude has also been described with pre-existing risk factors, which were excluded in this case through a review of the casualty's medical records. CVST can cascade in the setting of polycythemia, haemoconcentration, dehydration, vascular spasms, and cerebral circulatory disturbance produced by comorbid HACE. 12 The possibility of comorbid CVST and HACE in this patient cannot be conclusively excluded.
Neither diagnostic investigations such as computed tomography-venography, magnetic resonance venography, cerebral angiography or transcranial color-coded duplex sonography, nor pre-emptive etiological investigations regarding coagulation parameters are available at extreme altitude. 6, 7 Death is attributable to herniation caused by mass effect in CVST. CVST has been unnoticed and has been reported at autopsy as in this case. 6, 14 It has also been reported in fatal cases of HACE. 15 Treatment modalities with anticoagulation, thrombolysis, and mannitol administration are dependent on diagnosis and require monitoring under intensive care due to the risk of hemorrhage into venous infarcts. Immediate treatment with repeated doses of low molecular weight heparin, even if initiated at extreme altitude, may need to be continued for weeks or months at an institutional facility depending upon the extent of the thrombosis. Certain cases of CVST may be associated with prothrombotic states, wherein chronic warfarin therapy and monitoring of prothrombin time and INR is mandated. Therapeutic lumbar puncture and surgical intervention may be helpful.
